One of the main challenges in stability testing for cancer therapies is the complexity of the formulations. Many cancer drugs are biologics that are sensitive to environmental conditions. Additionally, long term testing requires significant time and resources, which can delay the availability of potentially life-saving treatments. Another challenge is the need for advanced analytical techniques to accurately detect and quantify degradation products.
